How a Healthcare Platform Turned Off-Limits Data Into Revenue

A healthcare platform sat on clinical data too sensitive to touch. A de-identification layer now strips PHI and Part 2 fields — turning legal liability into a sellable data asset.

New revenue

From once-untouchable data

2–4 months

Implementation Time

Zach Shapiro

Founder & CEO

OutcomeCatalyst

Connect ↓

The Challenge

The platform was sitting on a large, valuable clinical dataset riddled with the most sensitive categories of protected health information, including substance-use-disorder data governed by 42 CFR Part 2, which is far stricter than ordinary HIPAA PHI. That sensitivity made the data effectively untouchable: it could not be shared, analyzed with outside tools, or monetized without enormous legal exposure. A real revenue asset was trapped behind compliance risk.

What They Built

OutcomeCatalyst built a de-identification layer that safely strips and protects both standard PHI and the extra-restricted SUD / Part 2 data inside a compliant environment — turning records that were legally radioactive into clean, structured data the business could actually use and package.

The platform's clinical dataset was valuable but effectively untouchable: it carried the most sensitive categories of PHI, including substance-use-disorder data governed by 42 CFR Part 2, which is far stricter than ordinary HIPAA. The project initially scoped de-identifying structured PHI, but mid-way the team discovered the data was far messier than the client realized — sensitive categories, including PHI-SUD data, were tangled inside clinical free-text notes, each carrying a different handling and compliance burden. OutcomeCatalyst built a de-identification layer that strips and protects both standard PHI and the extra-restricted Part 2 / SUD data — including what was buried in free text — inside a compliant environment. The work treated compliance as the unlock rather than the obstacle, engineering the output to be clean, structured, and safe to use and package. With the legal risk removed, data that had been pure liability became an asset the business could actually put to work.

AI Role

NLP and extraction to detect and de-identify protected health information — including SUD/Part 2 categories buried in clinical free-text notes — inside a compliant environment.

Infrastructure

Source clinical dataset — structured PHI plus clinical free-text notes • Compliant de-identification processing environment

Integration Points

Impact

New revenue stream unlocked

Data that was previously impossible to touch became a monetizable data asset — a new revenue stream created out of what had been pure liability.

42 CFR Part 2 + PHI handled

De-identification covers both standard HIPAA PHI and the stricter substance-use-disorder (Part 2) categories inside a compliant environment.

Liability turned into an asset

Records that could not be shared, analyzed, or monetized without major legal exposure became clean, structured, packageable data.

Technology Utilized

Implementation Complexity

Revenue Growth

Risk & Compliance

Best Fit For

Healthcare platforms, payers, and life-sciences firms holding sensitive clinical datasets (including 42 CFR Part 2 / SUD data) that are blocked from analysis or monetization by compliance risk.

Zach Shapiro

Founder & CEO

OutcomeCatalyst

OutcomeCatalyst turns fragmented, underused data into measurable revenue, recovered time, and sharper decisions for operators and investors.

Connect with the Expert

Industry:

Healthcare & Life Sciences

Business Function:

Finance & Accounting

Operations

Company Size:

51-250

Project Cost:

$100K – $250K

Ownership:

Private Equity-Backed

Organization Type:

Private Company

AI Pattern:

Natural Language Processing

Document Processing & Extraction

Value Type:

Revenue Growth

Risk & Compliance

AI Model:

Multi-model platform

Frequently Asked Questions

How did a healthcare platform turn restricted clinical data into a new revenue stream?

The team built a de-identification layer that safely strips and protects both standard HIPAA PHI and the stricter substance-use-disorder data governed by 42 CFR Part 2, inside a compliant environment. That turned records that were legally untouchable into clean, structured data the business could use and package, unlocking a new revenue stream.

What AI approach and tools were used?

The approach used natural-language processing and document processing/extraction to identify and strip protected health information — including SUD / Part 2 categories buried in clinical free-text notes — within a compliant environment.

What results did the platform achieve?

Data that previously could not be shared, analyzed with outside tools, or monetized became a monetizable data asset and a new revenue stream — created out of what had been pure compliance liability.

How long did the engagement take?

About 16 weeks from kickoff.

Who is this de-identification approach best for?

Healthcare platforms, payers, and life-sciences firms holding sensitive clinical datasets — including 42 CFR Part 2 / substance-use-disorder data — that are blocked from analysis or monetization by compliance risk.